Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 88, Topic 1
In Progress

Foundational Principles: Pathophysiology, Epidemiology, and Risk Factors

Lesson Progress
0% Complete
Foundational Principles of Acid–Base Disorders

Foundational Principles: Pathophysiology, Epidemiology, and Risk Factors of Acid–Base Disorders

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Lesson Objective

Describe the foundational principles of acid–base homeostasis, its epidemiology in critical illness, and risk factors including chronic diseases and social determinants.

1. Epidemiology and Incidence in Critical Illness

Acid–base disturbances are among the most common laboratory abnormalities in the intensive care unit (ICU). They frequently manifest as complex mixed disorders and are strongly correlated with patient outcomes, including mortality and length of stay.

Prevalence and Mortality

  • Prevalence: Up to 70% of ICU patients exhibit mixed acid–base disorders. Single disturbances, such as metabolic acidosis or respiratory alkalosis, are identified in 30–50% of admissions.
  • Mortality Correlation: The severity of the disturbance is directly linked to risk. An admission arterial pH below 7.20 can double the risk of ICU mortality compared to a pH in the normal range. Furthermore, conditions like non-anion gap metabolic acidosis are predictive of prolonged mechanical ventilation and the need for renal replacement therapy (RRT).

Common Etiologies in the ICU

  1. Sepsis: Leads to lactic acidosis through a combination of tissue hypoperfusion and direct mitochondrial dysfunction.
  2. Shock States (Cardiogenic, Hypovolemic): Often cause a mixed acidosis due to impaired CO₂ elimination (respiratory component) and poor hydrogen ion (H⁺) clearance (metabolic component).
  3. Acute Kidney Injury (AKI): Results in the accumulation of uremic organic acids and a failure to regenerate bicarbonate (HCO₃⁻).
  4. Toxin Ingestions: Classic causes of high-anion gap metabolic acidosis include ethylene glycol, methanol, and salicylates.

Case Vignette

A 58-year-old with septic shock presents with pH 7.18, PaCO₂ 32 mm Hg, HCO₃⁻ 11 mEq/L, and an anion gap of 20 mEq/L. This presentation warrants immediate lactate-guided resuscitation. Bicarbonate therapy may be considered if the pH remains ≤ 7.20 and the patient exhibits persistent hemodynamic instability.

Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: The Importance of the Anion Gap and Delta Ratio

Always calculate the anion gap (AG = Na⁺ – [Cl⁻ + HCO₃⁻]) on initial assessment. In patients with suspected hypoalbuminemia, which is common in the ICU, the AG must be corrected to avoid misclassification. Furthermore, calculating the delta ratio (ΔAG / ΔHCO₃⁻) can help unmask mixed disorders, guiding more targeted therapy and improving prognostication.

2. Acid–Base Physiology Overview

The body maintains a tightly controlled physiologic pH between 7.35 and 7.45. This delicate balance is governed by three primary mechanisms: chemical buffering systems, respiratory regulation of carbon dioxide, and renal handling of bicarbonate and hydrogen ions.

Acid-Base Homeostasis Diagram A seesaw diagram illustrating the balance of acid-base homeostasis. The lungs control PaCO₂ (acid) on one side, and the kidneys control HCO₃⁻ (base) on the other, balancing on a fulcrum labeled pH 7.4. Acid-Base Homeostasis: A Balancing Act pH 7.4 Lungs PaCO₂ (Acid) Fast Compensation (minutes) Kidneys HCO₃⁻ (Base) Slow Compensation (hours-days)
Figure 1: Organ-Based Regulation of pH. The lungs provide rapid compensation by adjusting PaCO₂, while the kidneys offer slower but more definitive regulation by modulating HCO₃⁻ levels.
  • Extracellular Buffers: The bicarbonate/carbonic acid system is the most important extracellular buffer, governed by the Henderson–Hasselbalch equation: pH = pKₐ + log([HCO₃⁻] / [0.03 × PaCO₂]). Non-bicarbonate buffers like hemoglobin and plasma proteins contribute about 40% of the total buffering capacity.
  • Respiratory Regulation: The lungs can alter pH within minutes. Increased minute ventilation blows off CO₂, decreasing PaCO₂ and raising pH. Conversely, hypoventilation retains CO₂, lowering pH. Conditions causing V/Q mismatch, like ARDS or COPD, impair this response.
  • Renal Regulation: This is a slower process, taking hours to days. The kidneys regulate acid-base balance by: (1) reclaiming filtered HCO₃⁻ in the proximal tubule, (2) generating new HCO₃⁻ via ammoniagenesis, and (3) secreting H⁺ in the distal tubule.

3. Pathophysiology of Primary Disorders

Acid–base disorders are classified by the primary disturbance (metabolic or respiratory) and the direction of the pH change (acidosis or alkalosis). A systematic approach is crucial for accurate diagnosis.

A. Metabolic Acidosis

Defined by a primary decrease in serum HCO₃⁻, metabolic acidosis is broadly classified based on the anion gap.

Common Causes of High Anion Gap Metabolic Acidosis (GOLD MARK Mnemonic)
Mnemonic Cause Clinical Context
GGlycols (ethylene, propylene)Antifreeze ingestion, some medications
OOxoprolineChronic acetaminophen use, often in malnourished patients
LL-LactateSepsis, shock, hypoperfusion (most common cause)
DD-LactateShort-bowel syndrome, bacterial overgrowth
MMethanolWindshield washer fluid, “moonshine”
AAspirin (Salicylates)Overdose, often presents as a mixed disorder
RRenal Failure (Uremia)Acute or chronic kidney disease
KKetoacidosisDiabetic (DKA), alcoholic, starvation

Compensation: The expected respiratory compensation can be estimated using Winter’s formula: Expected PaCO₂ ≈ (1.5 × HCO₃⁻) + 8 ± 2.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Correcting the Anion Gap

Albumin is a major unmeasured anion. In hypoalbuminemia, the calculated anion gap may be falsely normal. Always correct the AG for low albumin using the formula: Corrected AG = Measured AG + [2.5 × (4.0 − albumin in g/dL)]. This prevents missing a significant anion gap metabolic acidosis.

B. Metabolic Alkalosis

Characterized by a primary increase in serum HCO₃⁻. Classification is based on urinary chloride, which helps determine the underlying cause and guide therapy.

  • Chloride-Responsive (Urine Cl⁻ < 20 mEq/L): Caused by loss of chloride-rich fluids (e.g., vomiting, NG suction) or diuretic use. Treatment involves volume repletion with isotonic saline and potassium chloride (KCl).
  • Chloride-Unresponsive (Urine Cl⁻ > 20 mEq/L): Associated with states of mineralocorticoid excess (e.g., hyperaldosteronism). Treatment targets the underlying cause, often involving mineralocorticoid blockade (spironolactone) or acetazolamide to promote bicarbonate excretion.

C. Respiratory Acidosis

Caused by alveolar hypoventilation, leading to an increase in PaCO₂ and a drop in pH. The degree of metabolic compensation distinguishes acute from chronic forms.

  • Acute: For every 10 mm Hg increase in PaCO₂, HCO₃⁻ rises by 1 mEq/L.
  • Chronic: For every 10 mm Hg increase in PaCO₂, HCO₃⁻ rises by 3–4 mEq/L due to renal compensation.

Management focuses on improving ventilation by treating the underlying cause (e.g., reversing sedation, bronchodilators for COPD) or providing mechanical support.

D. Respiratory Alkalosis

Caused by alveolar hyperventilation, leading to a decrease in PaCO₂ and a rise in pH. It is often a sign of an underlying systemic problem like pain, anxiety, sepsis, or hypoxemia. Management is directed at treating the trigger rather than the alkalosis itself.

4. Impact of Chronic Diseases

Pre-existing chronic conditions, particularly CKD and COPD, significantly alter a patient’s baseline acid-base status and their response to acute insults.

A. Chronic Kidney Disease (CKD)

In CKD, the kidneys’ ability to excrete the daily acid load and regenerate bicarbonate is impaired. This leads to a chronic, often asymptomatic, metabolic acidosis. This baseline state means that an acute acidotic insult can cause a more profound and rapid drop in pH. Early oral bicarbonate supplementation may slow CKD progression.

B. Chronic Obstructive Pulmonary Disease (COPD)

Patients with severe COPD have chronic respiratory acidosis (hypercapnia) due to impaired CO₂ elimination. The kidneys compensate by retaining bicarbonate, leading to a baseline serum HCO₃⁻ that is often 28–34 mEq/L. During an acute exacerbation, they develop an acute-on-chronic respiratory acidosis. A key pitfall is the rapid correction of hypercapnia with mechanical ventilation, which can precipitate a severe post-hypercapnic metabolic alkalosis, potentially causing seizures.

5. Social Determinants of Health (SDoH)

Socioeconomic factors, medication access, health literacy, and nutrition can significantly influence a patient’s risk for developing severe acid-base disorders and their outcomes.

  • Medication Access & Adherence: Gaps in insurance or pharmacy access can prevent patients with CKD or COPD from receiving necessary medications, leading to poorly controlled disease and a higher risk of acute decompensation.
  • Health Literacy: A limited understanding of symptoms like dyspnea or confusion can lead to delayed presentation to the hospital, by which time the acid-base disturbance is more severe.
  • Nutrition & Socioeconomic Factors: Malnutrition, common in lower socioeconomic groups, reduces the synthesis of buffer proteins. Diets high in processed foods can contribute to hyperchloremic states, while high animal protein intake increases the chronic dietary acid load.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Integrating SDoH into Clinical Care

Screening for social determinants of health should be a routine part of the admission process. Identifying barriers like medication cost, transportation issues, or low health literacy allows the clinical team to engage social work and case management early. This proactive approach can tailor education, secure resources, and ultimately help prevent readmissions for similar issues.

References

  1. Allgaier RL, Hodkinson P, Hodkinson B, et al. The frequency of acid–base disorders on admission to the intensive care unit: a retrospective cohort study. Crit Care. 2022;26(1):196.
  2. Barletta JF, Muir J, Brown J, Dzierba A. A systematic approach to understanding acid–base disorders in the critically ill. Ann Pharmacother. 2024;58(1):65–75.
  3. Dickerson RN. Fluids, electrolytes, acid–base disorders and nutrition support. In: ACCP/SCCM Critical Care Pharmacy Preparatory Review and Recertification Course. 2016.
  4. Kraut JA, Madias NE. Acid–Base Disorders in the Critically Ill Patient. Clin J Am Soc Nephrol. 2023;18(1):102–112.
  5. Kraut JA, Madias NE. Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol. 2007;2(1):162–174.
  6. Jaber S, Paugam C, Futier E, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled trial. Lancet. 2018;392(10141):31–40.
  7. Sharma S, Kaushik RM, Kaushik R. Acid base disorders in intensive care unit: a hospital-based study. Int J Adv Med. 2019;6(1):62–65.
  8. Zhou Y, Li X, Chen Y, et al. Health disparities in the risk of severe acidosis: real-world evidence from a diverse cohort. J Am Med Inform Assoc. 2024;31(12):2932–2939.
  9. Lim CY, Tan HK, Lee JH. Approach to acid–base disorders in primary care. Singap Med J. 2024;65(2):106–110.
  10. Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis. 2005;45(6):978–993.